丹奥治疗急性脑梗死的疗效及对血小板的影响  

Effect of Ozagrel Sodium on patient with acute cerebral infarction and on number of platelet

作　　者：田小军[1] 宋志秀[1] 吉四辈[1] 王玉梅[1] 

机构地区：[1]河南新乡医学院第一附属医院神经内科,河南新乡453100

出　　处：《中国民康医学》2005年第7期349-350,共2页Medical Journal of Chinese People’s Health

摘　　要：目的:观察丹奥治疗急性脑梗死(ACI)的疗效及对血小板数量的影响。方法:64例ACI患者分为治疗组(34例)和对照组(30例),治疗组静脉滴注丹奥;对照组静脉滴注低分子右旋糖苷及维脑路通。观察两组患者治疗前后临床神经功能缺损程度评分、Barthel日常生活能力指数及血小板数量的变化。结果:治疗组总有效率为88.23%,明显高于对照组的63.33%(P<0.05)。治疗组神经功能缺损程度评分和Barthel指数改变亦均优于对照组(P<0.05)。血小板数量变化无统计学意义。结论:丹奥可以作为治疗ACI的有效药物,为错过了发病早期溶栓最佳时机的患者提供一个新的治疗方法。objictive:To observe the effect of DAN-AO on patients with acute cerebral infarction (ACI) and on number of platelet. Methods:64 patients with ACI were divided into treatment group and control group. The clinical defection degree of nerve function (CDDNF), Barthel daily life ability index (BDLAI) and the number of blood platelets were observed before and after treatment. Results:The efficient rate of treatment group was remarkably increased than that of control group (88.23% vs 63.33%, P<0.05). The changes of CDDNF and BDLAI on treatment group were also better than that of control group (P<0.05). However, the change on the number of platelet was not significant. Conclusions:DAN-AO is a efficient drug on patient with ACI.

关 键 词：急性脑梗死 丹奥 

分 类 号：R972.4[医药卫生—药品] R743.33[医药卫生—药学]